These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
607 related articles for article (PubMed ID: 30587666)
1. Effect of Resistant Starch on the Gut Microbiota and Its Metabolites in Patients with Coronary Artery Disease. Yoshida N; Sasaki K; Sasaki D; Yamashita T; Fukuda H; Hayashi T; Tabata T; Osawa R; Hirata KI; Kondo A J Atheroscler Thromb; 2019 Aug; 26(8):705-719. PubMed ID: 30587666 [TBL] [Abstract][Full Text] [Related]
2. Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis. Yoshida N; Emoto T; Yamashita T; Watanabe H; Hayashi T; Tabata T; Hoshi N; Hatano N; Ozawa G; Sasaki N; Mizoguchi T; Amin HZ; Hirota Y; Ogawa W; Yamada T; Hirata KI Circulation; 2018 Nov; 138(22):2486-2498. PubMed ID: 30571343 [TBL] [Abstract][Full Text] [Related]
3. Variable responses of human microbiomes to dietary supplementation with resistant starch. Venkataraman A; Sieber JR; Schmidt AW; Waldron C; Theis KR; Schmidt TM Microbiome; 2016 Jun; 4(1):33. PubMed ID: 27357127 [TBL] [Abstract][Full Text] [Related]
4. Gut microbial features and dietary fiber intake predict gut microbiota response to resistant starch supplementation. Devarakonda SLS; Superdock DK; Ren J; Johnson LM; Loinard-González AAP; Poole AC Gut Microbes; 2024; 16(1):2367301. PubMed ID: 38913541 [TBL] [Abstract][Full Text] [Related]
5. Dysbiosis signatures of gut microbiota in coronary artery disease. Zhu Q; Gao R; Zhang Y; Pan D; Zhu Y; Zhang X; Yang R; Jiang R; Xu Y; Qin H Physiol Genomics; 2018 Oct; 50(10):893-903. PubMed ID: 30192713 [TBL] [Abstract][Full Text] [Related]
6. Characterization of fecal fat composition and gut derived fecal microbiota in high-fat diet fed rats following intervention with chito-oligosaccharide and resistant starch complexes. Shang W; Si X; Zhou Z; Li Y; Strappe P; Blanchard C Food Funct; 2017 Dec; 8(12):4374-4383. PubMed ID: 29068034 [TBL] [Abstract][Full Text] [Related]
7. Alterations in the gut microbiome and metabolism with coronary artery disease severity. Liu H; Chen X; Hu X; Niu H; Tian R; Wang H; Pang H; Jiang L; Qiu B; Chen X; Zhang Y; Ma Y; Tang S; Li H; Feng S; Zhang S; Zhang C Microbiome; 2019 Apr; 7(1):68. PubMed ID: 31027508 [TBL] [Abstract][Full Text] [Related]
8. Effects of Lactic Acid Bacteria-Fermented Soymilk on Isoflavone Metabolites and Short-Chain Fatty Acids Excretion and Their Modulating Effects on Gut Microbiota. Dai S; Pan M; El-Nezami HS; Wan JMF; Wang MF; Habimana O; Lee JCY; Louie JCY; Shah NP J Food Sci; 2019 Jul; 84(7):1854-1863. PubMed ID: 31206699 [TBL] [Abstract][Full Text] [Related]
9. Impact of Dietary Resistant Starch on the Human Gut Microbiome, Metaproteome, and Metabolome. Maier TV; Lucio M; Lee LH; VerBerkmoes NC; Brislawn CJ; Bernhardt J; Lamendella R; McDermott JE; Bergeron N; Heinzmann SS; Morton JT; González A; Ackermann G; Knight R; Riedel K; Krauss RM; Schmitt-Kopplin P; Jansson JK mBio; 2017 Oct; 8(5):. PubMed ID: 29042495 [TBL] [Abstract][Full Text] [Related]
10. Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill. Chen R; Wang J; Zhan R; Zhang L; Wang X J Ethnopharmacol; 2019 Nov; 244():112139. PubMed ID: 31401318 [TBL] [Abstract][Full Text] [Related]
11. Opportunistic bacteria confer the ability to ferment prebiotic starch in the adult cystic fibrosis gut. Wang Y; Leong LEX; Keating RL; Kanno T; Abell GCJ; Mobegi FM; Choo JM; Wesselingh SL; Mason AJ; Burr LD; Rogers GB Gut Microbes; 2019; 10(3):367-381. PubMed ID: 30359203 [TBL] [Abstract][Full Text] [Related]
12. Lotus Seed Resistant Starch Regulates Gut Microbiota and Increases Short-Chain Fatty Acids Production and Mineral Absorption in Mice. Zeng H; Huang C; Lin S; Zheng M; Chen C; Zheng B; Zhang Y J Agric Food Chem; 2017 Oct; 65(42):9217-9225. PubMed ID: 28954513 [TBL] [Abstract][Full Text] [Related]
13. Effects of Arabinoxylan and Resistant Starch on Intestinal Microbiota and Short-Chain Fatty Acids in Subjects with Metabolic Syndrome: A Randomised Crossover Study. Hald S; Schioldan AG; Moore ME; Dige A; Lærke HN; Agnholt J; Bach Knudsen KE; Hermansen K; Marco ML; Gregersen S; Dahlerup JF PLoS One; 2016; 11(7):e0159223. PubMed ID: 27434092 [TBL] [Abstract][Full Text] [Related]
14. The Glucoamylase Inhibitor Acarbose Has a Diet-Dependent and Reversible Effect on the Murine Gut Microbiome. Baxter NT; Lesniak NA; Sinani H; Schloss PD; Koropatkin NM mSphere; 2019 Feb; 4(1):. PubMed ID: 30728281 [TBL] [Abstract][Full Text] [Related]
15. Integrative Analysis of Gut Microbiota and Fecal Metabolites in Rats after Prednisone Treatment. Zhang J; Feng D; Law HK; Wu Y; Zhu GH; Huang WY; Kang Y Microbiol Spectr; 2021 Dec; 9(3):e0065021. PubMed ID: 34756061 [TBL] [Abstract][Full Text] [Related]
16. Inulin-type fructans improve active ulcerative colitis associated with microbiota changes and increased short-chain fatty acids levels. Valcheva R; Koleva P; Martínez I; Walter J; Gänzle MG; Dieleman LA Gut Microbes; 2019; 10(3):334-357. PubMed ID: 30395776 [TBL] [Abstract][Full Text] [Related]
17. Effects of Commercial Apple Varieties on Human Gut Microbiota Composition and Metabolic Output Using an In Vitro Colonic Model. Koutsos A; Lima M; Conterno L; Gasperotti M; Bianchi M; Fava F; Vrhovsek U; Lovegrove JA; Tuohy KM Nutrients; 2017 May; 9(6):. PubMed ID: 28538678 [TBL] [Abstract][Full Text] [Related]
18. Gut microbiota combined with metabolites reveals unique features of acute myocardial infarction patients different from stable coronary artery disease. Dong C; Yang Y; Wang Y; Hu X; Wang Q; Gao F; Sun S; Liu Q; Li L; Liu J; Tang Y; Zhang S; Wu C; Zhu H J Adv Res; 2023 Apr; 46():101-112. PubMed ID: 35750287 [TBL] [Abstract][Full Text] [Related]
19. Changes in gut microbiota in predigested Hibiscus sabdariffa L calyces and Agave (Agave tequilana weber) fructans assessed in a dynamic in vitro model (TIM-2) of the human colon. Sáyago-Ayerdi SG; Zamora-Gasga VM; Venema K Food Res Int; 2020 Jun; 132():109036. PubMed ID: 32331660 [TBL] [Abstract][Full Text] [Related]
20. Resistant Starch Type 2 from Wheat Reduces Postprandial Glycemic Response with Concurrent Alterations in Gut Microbiota Composition. Hughes RL; Horn WH; Finnegan P; Newman JW; Marco ML; Keim NL; Kable ME Nutrients; 2021 Feb; 13(2):. PubMed ID: 33671147 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]